journal article·2019-11

Silencing of GFP expression in human mesenchymal stem cells using quaternary polyplexes of siRNA-PEI with glycosaminoglycans and albumin

Laura C. Herrera, V. Prasad Shastri

Acta Biomaterialia· Volume 99
Publisher page

Abstract

In recent years evidence has been mounting for a role for mesenchymal stem cells (MSCs) in immunomodulation, anti-inflammatory processes, and paracrine signaling via secreted extracellular vesicles. In order to exploit these biological functions, systems to efficiently deliver genetic material into MSCs would therefore be highly desirable. In this study, efficient silencing of GFP expression by combining high N/P ratio siRNA and branched PEI (bPEI) polyplexes (siRNA-bPEI) polyplexes with glycosaminoglycans (GAGs), namely hyaluronic acid (HA), chondroitin sulfate (CS) and heparin sulfate (HS), and human serum albumin (HSA) is reported. These quaternary systems were characterized using surface charge, size and morphology and applied to MSCs, which represent a challenge due to their typically low transfection efficiency. The quaternary polyplexes promoted efficient charge shielding and release of siRNA in the cytoplasm with reduced toxicity. A high silencing efficiency of >90% (i.e., less than 10% remaining GFP expression) was achieved with noticeably reduced cellular toxicity, especially with siRNA-bPEI polyplexes modified with HA and HA + HSA. In general addition of GAGs led to more compact polyplexes. Endocytosis studies point to improved endosomal escape at high N/P ratios as a reason for high transfection efficiency and a role for hyaluronic acid in the uptake mechanism likely via CD44 interactions. Co-localization studies showed the polyplexes are stable in the cytosol over time, which correlates with a proper disassembly and subsequent silencing of GFP. Furthermore, GAG containing polyplexes were frequently co-localized with the nucleus. These findings in sum suggest that PEI/HSA/GAG based quaternary polyplexes are promising as transfection agents for MSCs. STATEMENT OF SIGNIFICANCE: Since mesenchymal stem cells (MSCs) are recruited to the site of tissue repair and play a role in immunomodulation, anti-inflammatory processes, and paracrine signaling, they present an excellent target for genetic engineering. However, delivery of genetic material into MSCs is challenging. In this study, >97% silencing of constitutive green fluorescent protein expression in human MSCs (hMSCs) using high N/P ratio polyplexes of branched-PEI-siRNA incorporating glycosaminoglycan as a charge neutralizer and human serum albumin as co-complexing agent is demonstrated. In addition to possessing good cytocompatibility and excellent cytosolic stability; polyplexes incorporating GAGs also showed altered endocytic uptake, with incorporation of hyaluronic acid promoting caveolae-mediated entry. Our system highlights the importance of physiologically derived macromolecules in delivery of genetic material into hMSCs.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Mesenchymal stem cell research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (75)

Show source-provided references
1. The bone marrow niche for haematopoietic stem cells10.1038/nature12984 ↗
2. A novel Lipidoid-MicroRNA formulation promotes calvarial bone regeneration10.1016/j.biomaterials.2018.05.038 ↗
3. Optimizing surface-engineered ultra-small gold nanoparticles for highly efficient miRNA delivery to enhance osteogenic differentiation of bone mesenchymal stromal cells10.1007/s12274-016-1265-9 ↗
4. What's in a name?10.1089/ten.tea.2010.0216 ↗
5. Mesenchymal stem/stromal cell extracellular vesicles: from active principle to next generation drug delivery system10.1016/j.jconrel.2017.07.023 ↗
6. How to hit mesenchymal stromal cells and make the tumor microenvironment immunostimulant rather than immunosuppressive10.3389/fimmu.2018.00262 ↗
7. Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications10.1038/mt.2015.44 ↗
8. European Medicines Agency - - Alofisel.
9. First off-the-shelf mesenchymal stem cell therapy nears European approval10.1038/nbt0318-212a ↗
10. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans10.1038/35888 ↗
11. The promises and pitfalls of RNA-interference-based therapeutics10.1038/nature07758 ↗
12. Gene therapy returns to centre stage10.1038/nature15818 ↗
13. FDA-approved oligonucleotide therapies in 201710.1016/j.ymthe.2017.03.023 ↗
14. Knocking down disease: a progress report on siRNA therapeutics10.1038/nrg3978 ↗
15. Reprogramming of mouse and human cells to pluripotency using mature microRNAs10.1016/j.stem.2011.05.001 ↗
16. The let-7/LIN-41 pathway regulates reprogramming to human induced pluripotent stem cells by controlling expression of prodifferentiation genes10.1016/j.stem.2013.11.001 ↗
17. Advances in therapeutic bacterial antisense biotechnology10.1007/s00253-017-8671-0 ↗
18. Non-viral gene delivery systems for tissue repair and regeneration10.1186/s12967-018-1402-1 ↗
19. Lentiviral vectors, two decades later10.1126/science.aah6192 ↗
20. Engineering adeno-associated viruses for clinical gene therapy10.1038/nrg3742 ↗
21. Non-viral vectors for gene-based therapy10.1038/nrg3763 ↗
22. A simple and rapid nonviral approach to efficiently transfect primary tissue-derived cells using polyethylenimine10.1038/nprot.2012.038 ↗
23. Comparative evaluation and optimization of off-the-shelf cationic polymers for gene delivery purposes10.1039/C5PY00915D ↗
24. Size matters for in vitro gene delivery: investigating the relationships among complexation protocol, transfection medium, size and sedimentation10.1038/srep44134 ↗
25. Strategies to overcome the polycation dilemma in drug delivery10.1016/j.addr.2018.07.017 ↗
26. Polyethylenimine: a versatile, multifunctional non-viral vector for nucleic acid delivery10.1016/j.msec.2016.07.066 ↗
27. Polyethylenimine-based nanocarriers in co-delivery of drug and gene: a developing horizon10.1080/20022727.2018.1488497 ↗
28. Poly(ethylenimine) and its role in gene delivery10.1016/S0168-3659(99)00090-5 ↗
29. Lipid-like materials for low-dose, in vivo gene silencing10.1073/pnas.0910603106 ↗
30. An efficient, non-viral dendritic vector for gene delivery in tissue engineering10.1038/gt.2017.58 ↗
31. Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity10.1038/ncomms5277 ↗
32. Delivery materials for siRNA therapeutics10.1038/nmat3765 ↗
33. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles10.1016/j.jconrel.2008.05.010 ↗
34. Enhanced gene silencing through human serum albumin-mediated delivery of polyethylenimine-siRNA polyplexes10.1371/journal.pone.0122581 ↗
35. Albumin incorporation in polyethylenimine-DNA polyplexes influences transfection efficiency10.1021/acs.biomac.5b01308 ↗
36. Self-assembled human serum albumin-coated complexes for gene delivery with improved transfection
37. Medical application of glycosaminoglycans: a review
38. The sweet spot: how GAGs help chemokines guide migrating cells10.1189/jlb.3MR0915-440R ↗
39. Glycobiology simplified: diverse roles of glycan recognition in inflammation10.1189/jlb.3RI0116-021R ↗
40. Heparan sulfate: a ubiquitous glycosaminoglycan with multiple roles in immunity10.3389/fimmu.2013.00470 ↗
41. Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors10.1016/j.biomaterials.2013.01.077 ↗
42. Cluster of differentiation 44 targeted hyaluronic acid based nanoparticles for MDR1 siRNA delivery to overcome drug resistance in ovarian cancer10.1007/s11095-014-1602-1 ↗
43. Glycosaminoglycan-functionalized poly-lactide-co-glycolide nanoparticles: synthesis, characterization, cytocompatibility, and cellular uptake
44. Gresch · 2012 · 65
45. Optimization of high-efficiency transfection of adult human mesenchymal stem cells in vitro10.1385/MB:30:1:009 ↗
46. Efficient transfection method for primary cells10.1089/107632702753725003 ↗
47. A comparative study of non-viral gene delivery techniques to human adipose-derived mesenchymal stem cell10.3390/ijms150915044 ↗
48. Improving the Gene Transfection in Human Embryonic Stem Cells: Balancing with Cytotoxicity and Pluripotent Maintenance10.1021/acsami.6b00353 ↗
49. Multipotent mesenchymal stromal cells: optimization and comparison of five cationic polymer-based gene delivery methods10.1080/14653240802474307 ↗
50. Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs)10.1261/rna5160904 ↗
51. Molecular weight-dependent gene transfection activity of unmodified and galactosylated polyethyleneimine on hepatoma cells and mouse liver10.1016/S1525-0016(02)00053-9 ↗
52. Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO;2-Q ↗
53. Colloidal aggregation: from screening nuisance to formulation nuance10.1016/j.nantod.2018.02.011 ↗
54. Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer10.1002/jgm.598 ↗
55. Heparin promotes fibril formation by the N-terminal fragment of amyloidogenic apolipoprotein A-I10.1002/1873-3468.12426 ↗
56. Heparin and methionine oxidation promote the formation of apolipoprotein A-I amyloid comprising alpha-helical and beta-sheet structures10.1021/acs.biochem.6b01120 ↗
57. Polymer chemical structure is a key determinant of physicochemical and colloidal properties of polymer-DNA complexes for gene delivery
58. Formation and structure of PEI/DNA complexes: quantitative analysis10.1039/c1sm05449j ↗
59. Multilayer mediated forward and patterned siRNA transfection using linear-PEI at extended N/P ratios10.1016/j.actbio.2009.01.004 ↗
60. Exogenous and cell surface glycosaminoglycans alter DNA delivery efficiency of arginine and lysine homopeptides in distinctly different ways10.1074/jbc.M111.227793 ↗
61. Extracellular barriers to in vivo PEI and PEGylated PEI polyplex-mediated gene delivery to the liver10.1021/bc700388u ↗
62. Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes10.1016/j.ymthe.2005.03.038 ↗
63. Gene transfer by means of lipo- and polyplexes: role of clathrin and caveolae-mediated endocytosis10.1080/08982100600848819 ↗
64. Cellular uptake mechanisms of novel anionic siRNA lipoplexes10.1007/s11095-012-0952-9 ↗
65. Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae10.1073/pnas.1322356111 ↗
66. Search for inhibitors of endocytosis: Intended specificity and unintended consequences10.4161/cl.23967 ↗
67. Clathrin-mediated endocytosis in living host cells visualized through quantum dot labeling of infectious hematopoietic necrosis virus10.1128/JVI.00109-11 ↗
68. Minimal criteria for defining multipotent mesenchymal stromal cells
69. Mesenchymal stem cells: Identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche10.1016/j.ymeth.2015.09.016 ↗
70. Lipid raft-mediated regulation of hyaluronan-CD44 interactions in inflammation and cancer10.3389/fimmu.2015.00420 ↗
71. Antibodies to SPARC inhibit albumin binding to SPARC, gp60, and microvascular endothelium10.1152/ajpheart.1992.263.6.H1872 ↗
72. Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway10.1074/jbc.272.41.25968 ↗
73. A practical guide to evaluating colocalization in biological microscopy10.1152/ajpcell.00462.2010 ↗
74. Intracellular trafficking and exocytosis of a multi-component siRNA nanocomplex10.1016/j.nano.2016.02.003 ↗
75. Amphiphilic, low molecular weight poly(ethylene imine) derivatives with enhanced stability for efficient pulmonary gene delivery10.1002/jgm.1538 ↗